Skechers, known for its comfortable and affordable sneakers, agreed to a $9.4 billion deal to be taken private by 3G Capital.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The titanic port deal immediately made political waves, even as the seller, conglomerate CK Hutchison, denied politics were at play.
Prada reported retail sales across its brands rose 18% last year as the company reportedly gears up to buy Versace from Capri Holdings.
Here’s the bad news: Auto manufacturing is a notoriously thin-margin industry, and tariffs could tear right through those margins.
President Trump wants to bring film-making back to Hollywood by imposing 100% tariffs on movies produced outside of the US.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
As US-based streaming platforms chase audiences around the world, they’re increasingly committing to international productions.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
Last Tuesday, content conglomerate Thomson Reuters notched a big legal win against AI firm ROSS. Is it a sign of what’s to come?
De Beers, one of the largest companies in the diamond mining sector, has been battered by the ascendance of cheaper lab-grown gems.
The delay of Grand Theft Auto VI’s release threw a multibillion dollar wrench in forecasted revenues for a gaming industry in need of a hit.
It was only last year that 737 felt like the number of scandals Boeing was embroiled in, rather than the name of its narrow-body aircraft.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.